Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Elliott

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Patient|April 25, 2020
Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' ExperienceCarlos Capella-Peris, Mary M Cosgrove, Irene C Chrismer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 11, 2020
Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapyCarlos Capella-Peris, Mary M Cosgrove, Irene C Chrismer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 3, 2020
Correction to: Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapyCarlos Capella-Peris, Mary M Cosgrove, Irene C Chrismer, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|June 9, 2020
Assessing Motor Function in Congenital Muscular Dystrophy Patients Using AccelerometryTokunbor A Lawal, Joshua J Todd, Jeffrey S Elliott, et al.
Neurology|January 17, 2020
Randomized controlled trial of <i>N</i>-acetylcysteine therapy for <i>RYR1</i>-related myopathiesJoshua J Todd, Tokunbor A Lawal, Jessica W Witherspoon, et al.
Neuromuscular Disorders : NMD|January 15, 2017
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophyRoxanna M Bendixen, Jocelyn Butrum, Mina S Jain, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Patient|April 25, 2020
Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' ExperienceCarlos Capella-Peris, Mary M Cosgrove, Irene C Chrismer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 11, 2020
Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapyCarlos Capella-Peris, Mary M Cosgrove, Irene C Chrismer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 3, 2020
Correction to: Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapyCarlos Capella-Peris, Mary M Cosgrove, Irene C Chrismer, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|June 9, 2020
Assessing Motor Function in Congenital Muscular Dystrophy Patients Using AccelerometryTokunbor A Lawal, Joshua J Todd, Jeffrey S Elliott, et al.
Neurology|January 17, 2020
Randomized controlled trial of <i>N</i>-acetylcysteine therapy for <i>RYR1</i>-related myopathiesJoshua J Todd, Tokunbor A Lawal, Jessica W Witherspoon, et al.
Neuromuscular Disorders : NMD|January 15, 2017
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophyRoxanna M Bendixen, Jocelyn Butrum, Mina S Jain, et al.
Pageof 1